Bulovka Hospital is a large teaching hospital complex in Prague, situated on a hillock adjoining the White Rock in Prague 8 - Libeň near the defunct homestead of Bulovka. The most striking building in the complex is the hospital's famous neo-Rococo building called Vychovatelna.

During the past decade, Nemocnice Na Bulovce conducted 54 clinical trials. In the 10-year time frame, 54 clinical trials started and 34 clinical trials were completed, i.e. on average, 63% percent of trials that started reached the finish line to date. In the past 5 years, 31 clinical trials started and 23 clinical trials were completed. i.e. 74.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nemocnice Na Bulovce" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "Pfizer" with 9 trials sponsored, "Eli Lilly and Company" with 6 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored and "Bayer" with 4 trials sponsored. Other sponsors include 53 different institutions and companies that sponsored additional 48 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nemocnice Na Bulovce" #1 collaborator was "Merck Sharp & Dohme LLC" with 4 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator and "Gynecologic Oncology Group" with 2 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 38 trials.

According to Clinical.Site data, the most researched conditions in "Nemocnice Na Bulovce" are "Idiopathic Pulmonary Fibrosis" (8 trials), "Ulcerative Colitis" (8 trials), "Atopic Dermatitis" (4 trials), "Breast Cancer" (4 trials) and "Melanoma" (3 trials). Many other conditions were trialed in "Nemocnice Na Bulovce" in a lesser frequency.

Most popular intervention types in "Nemocnice Na Bulovce" are "Drug" (76 trials), "Biological" (8 trials), "Other" (5 trials), "Device" (3 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (31 trials), "Carboplatin" (5 trials), "Cisplatin" (4 trials), "Paclitaxel" (4 trials) and "Pembrolizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Nemocnice Na Bulovce" are 76 trials for "All" genders, 10 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are 30 active trials in "Nemocnice Na Bulovce". 1 are not yet recruiting, 12 are recruiting, 16 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 47 completed trials in Nemocnice Na Bulovce, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Nemocnice Na Bulovce, 2 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 53 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 1 trials that are defined as “Not Applicable".

Nemocnice Na Bulovce has several departments that took part in Clinical trials: "Lekarske Fakulty Univerzity Karlovy Fakultni Nemocnice Na Bulovce; Ustav Radiacni Onkologie" - 4 trials, "Infection Diseases and AIDS Treatment ClinicUniversity Hospital with Outpatient Clinic" - 3 trials